Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Deloitte
Cipla
Queensland Health
Fish and Richardson
Moodys
UBS
Cerilliant
McKesson

Generated: May 21, 2018

DrugPatentWatch Database Preview

EMETE-CON Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Emete-con, and when can generic versions of Emete-con launch?

Emete-con is a drug marketed by Pfizer and Roerig and is included in two NDAs.

The generic ingredient in EMETE-CON is benzquinamide hydrochloride. Additional details are available on the benzquinamide hydrochloride profile page.
Summary for EMETE-CON
US Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: 17
Patent Applications: 13
DailyMed Link:EMETE-CON at DailyMed
Drug patent expirations by year for EMETE-CON
Synonyms for EMETE-CON
[3-(diethylcarbamoyl)-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl] acetate hydrochloride
113-69-9
2-(Acetyloxy)-N,N-diethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]quinolizine-3-carboxamide Hydrochloride
2-Acetoxy-3-diethylcarbamoyl-9,10-dimethoxyhexahydrobenzo(a)quinolizine hydrochloride
2H-Benzo(a)quinolizine-3-carboxamide, N,N-diethyl-1,3,4,6,7,11b-hexahydro-2-hydroxy-9,10-dimethoxy-, acetate (ester), hydrochloride
3-(diethylcarbamoyl)-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-yl acetate hydrochloride(1:1)
3-(DIETHYLCARBAMOYL)-9,10-DIMETHOXY-1H,2H,3H,4H,6H,7H,11BH-PYRIDO[2,1-A]ISOQUINOLIN-2-YL ACETATE HYDROCHLORIDE
3-(Diethylcarbamoyl)-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl acetate hydrochloride
3-Carbamoyl-N,N-diethyl-1,3,4,6,7,11b-hexahydro-9,11-dimethoxy-2H-benzo(a)quinolizin-2-yl acetate hydrochloride
AC1L2R4P
AC1Q3E0J
AK516612
AKOS027446656
Benzochinamide hydrochloride
Benzoquinamide hydrochloride
Benzquinamida clorhidrato
Benzquinamida clorhidrato [Spanish]
Benzquinamide HCl
Benzquinamide hydrochloride
CHEMBL1200707
EINECS 204-033-3
FT-0662620
LS-40206
NSC 64375
P-2647 hydrochloride
PL028575
SCHEMBL1087285

US Patents and Regulatory Information for EMETE-CON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer EMETE-CON benzquinamide hydrochloride INJECTABLE;INJECTION 016820-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Roerig EMETE-CON benzquinamide hydrochloride SUPPOSITORY;RECTAL 016818-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
UBS
Colorcon
Moodys
Julphar
Medtronic
Cantor Fitzgerald
Chinese Patent Office
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.